Perincheri S - Search Results

1

Monobody adapter for functional antibody display on nanoparticles for adaptable targeted delivery applications.

Albert C, Bracaglia L, Koide A, DiRito J, Lysyy T, Harkins L, Edwards C, Richfield O, Grundler J, Zhou K, Denbaum E, Ketavarapu G, Hattori T, Perincheri S, Langford J, Feizi A, Haakinson D, Hosgood SA, Nicholson ML, Pober JS, Saltzman WM, Koide S, Tietjen GT. Albert C, et al. Among authors: perincheri s. Nat Commun. 2022 Oct 11;13(1):5998. doi: 10.1038/s41467-022-33490-8. Nat Commun. 2022. PMID: 36220817 Free PMC article.

2

Cellular recovery after prolonged warm ischaemia of the whole body.

Andrijevic D, Vrselja Z, Lysyy T, Zhang S, Skarica M, Spajic A, Dellal D, Thorn SL, Duckrow RB, Ma S, Duy PQ, Isiktas AU, Liang D, Li M, Kim SK, Daniele SG, Banu K, Perincheri S, Menon MC, Huttner A, Sheth KN, Gobeske KT, Tietjen GT, Zaveri HP, Latham SR, Sinusas AJ, Sestan N. Andrijevic D, et al. Among authors: perincheri s. Nature. 2022 Aug;608(7922):405-412. doi: 10.1038/s41586-022-05016-1. Epub 2022 Aug 3. Nature. 2022. PMID: 35922506 Free PMC article.

3

"Double-hit" ineffective erythropoiesis-concurrent β-thalassemia with α-gene triplication and myelodysplastic syndrome with SF3B1 mutation.

Chen PH, Gorshein E, Tormey C, Siddon AJ, Perincheri S. Chen PH, et al. Among authors: perincheri s. Am J Hematol. 2023 Jun;98(6):984-988. doi: 10.1002/ajh.26856. Epub 2023 Feb 14. Am J Hematol. 2023. PMID: 36688500 No abstract available.

4

Intravascular Large B-Cell Lymphoma: Clinical and Histopathologic Findings.

Charifa A, Paulson N, Levy L, Perincheri S, Lee A, McNiff JM, Ko CJ. Charifa A, et al. Among authors: perincheri s. Yale J Biol Med. 2020 Mar 27;93(1):35-40. eCollection 2020 Mar. Yale J Biol Med. 2020. PMID: 32226333 Free PMC article.

5

Favorable outcome associated with an IGF-1 ligand signature in breast cancer.

Mu L, Tuck D, Katsaros D, Lu L, Schulz V, Perincheri S, Menato G, Scarampi L, Harris L, Yu H. Mu L, et al. Among authors: perincheri s. Breast Cancer Res Treat. 2012 May;133(1):321-31. doi: 10.1007/s10549-012-1952-5. Breast Cancer Res Treat. 2012. PMID: 22297468

6

Molecular testing of isolated myeloid sarcoma allows successful FLT3-targeted therapy.

Shallis RM, Pucar D, Perincheri S, Gore SD, Seropian SE, Podoltsev NA, Zeidan AM. Shallis RM, et al. Among authors: perincheri s. Ann Hematol. 2022 May;101(5):1145-1147. doi: 10.1007/s00277-021-04702-w. Epub 2021 Oct 22. Ann Hematol. 2022. PMID: 34686913 No abstract available.

7

Tumor Microenvironment of Lymphomas and Plasma Cell Neoplasms: Broad Overview and Impact on Evaluation for Immune Based Therapies.

Perincheri S. Perincheri S. Front Oncol. 2021 Dec 8;11:719140. doi: 10.3389/fonc.2021.719140. eCollection 2021. Front Oncol. 2021. PMID: 34956859 Free PMC article. Review.

8

Severity of Coexisting Diabetic Glomerular Lesions Affects Outcomes in Primary Glomerular Disease.

Perincheri S. Perincheri S. Kidney360. 2023 Oct 1;4(10):1345-1346. doi: 10.34067/KID.0000000000000267. Kidney360. 2023. PMID: 37883998 Free PMC article. No abstract available.

9

IRF8 may be a useful marker for blastic plasmacytoid dendritic cell neoplasm, especially with weak CD123 expression.

Tang H, Panse G, Braddock D, Perincheri S, Xu ML, McNiff JM. Tang H, et al. Among authors: perincheri s. J Cutan Pathol. 2023 Jul;50(7):595-600. doi: 10.1111/cup.14439. Epub 2023 Apr 21. J Cutan Pathol. 2023. PMID: 37082914

10

Chronic Retiform Purpura of the Abdomen and Thighs: A Fatal Case of Intravascular Large Cell Lymphoma.

Ugwu N, Kibbi N, Perincheri S, Antaya RJ. Ugwu N, et al. Among authors: perincheri s. Cutis. 2022 Jun;109(6):E12-E14. doi: 10.12788/cutis.0552. Cutis. 2022. PMID: 35960983 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page